Literature DB >> 11844474

Relationship between beta-AP peptide aggregation and microglial activation.

Carme Casal1, Joan Serratosa, Josep M Tusell.   

Abstract

We compared the relationship between the state of aggregation of two peptides (beta-AP 25-35 and beta-AP 1-42) and microglial activation. After 7 days at 37 degrees C beta-AP 25-35 was in an amorphous state and did not activate microglial cells. In the same conditions, aggregated beta-AP 1-42 activated these cells and caused changes in microglial ramification, increasing the proliferation index and inducing tumor necrosis factor alpha (TNF alpha) release. Neither peptide induced a release of nitric oxide (NO). As the toxicity of beta-AP peptides in cell culture is associated with the formation of amyloid fibrils, we also examined the toxicity of both peptides in microglial cell cultures and in PC 12 cell cultures. The results suggest that the two beta-AP fragments studied have similar neurotoxic effects but different pro-inflammatory activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844474     DOI: 10.1016/s0006-8993(01)03362-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Authors:  Belén G Ramírez; Cristina Blázquez; Teresa Gómez del Pulgar; Manuel Guzmán; María L de Ceballos
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

2.  Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats.

Authors:  Sara Johansson; Ann-Cathrin Radesäter; Richard F Cowburn; Johan Thyberg; Johan Luthman
Journal:  Exp Brain Res       Date:  2005-09-21       Impact factor: 1.972

3.  Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation.

Authors:  Luigi Franchi; Tatjana Eigenbrod; Gabriel Núñez
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

4.  Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects.

Authors:  Feifei Xi; Feng Sang; Chunxiang Zhou; Yun Ling
Journal:  Neural Regen Res       Date:  2012-12-25       Impact factor: 5.135

5.  Root-Securing and Brain-Fortifying Liquid Upregulates Caveolin-1 in Cell Model with Alzheimer's Disease through Inhibiting Tau Phosphorylation.

Authors:  Depei Yuan; Chuhua Zeng; Qianfeng Chen; Fengjie Wang; Lin Yuan; Yaoqian Zhu; Ziyang Shu; Ning Chen
Journal:  Neurol Res Int       Date:  2017-10-16

Review 6.  NADPH oxidase as a therapeutic target in Alzheimer's disease.

Authors:  Michelle L Block
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

7.  Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition.

Authors:  Michael W Marlatt; Jan Bauer; Eleonora Aronica; Elise S van Haastert; Jeroen J M Hoozemans; Marian Joels; Paul J Lucassen
Journal:  Neural Plast       Date:  2014-08-19       Impact factor: 3.599

Review 8.  Spotlight on the NLRP3 inflammasome pathway.

Authors:  Marine Groslambert; Bénédicte F Py
Journal:  J Inflamm Res       Date:  2018-09-25

9.  Dexmedetomidine reduces hippocampal microglia inflammatory response induced by surgical injury through inhibiting NLRP3.

Authors:  Ji Peng; Peng Zhang; Han Zheng; Yun-Qin Ren; Hong Yan
Journal:  Chin J Traumatol       Date:  2019-04-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.